av/dr-reddys--big.svg

NYSE:RDY

Dr. Reddy's Laboratories Limited

  • Stock

USD

Last Close

5,811.60

21/05 10:00

Market Cap

973.05B

Beta: 0.24

Volume Today

491.29K

Avg: 213.67K

PE Ratio

19.34

PFCF: 35.19

Dividend Yield

0.02%

Payout:12.73%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
119.99B
-
24.76B
79.37%
25.55B
3.20%
27.05B
5.87%
28.81B
6.49%
31.33B
8.76%
34.32B
9.54%
40.24B
17.24%
48.15B
19.66%
49.78B
3.38%
average payables
64.56B
-
10.58B
83.61%
11.48B
8.49%
12.86B
12.01%
14.73B
14.59%
15.30B
3.85%
12.65B
17.34%
16.33B
29.11%
23.74B
45.40%
24.13B
1.62%
average receivables
181.02B
-
46.37B
74.39%
50.34B
8.57%
49.71B
1.26%
47.17B
5.11%
44.23B
6.23%
52.51B
18.73%
57.07B
8.68%
61.22B
7.27%
71.27B
16.42%
book value per share
533.98
-
653.51
22.38%
752.49
15.15%
744.34
1.08%
762.52
2.44%
844.99
10.82%
934.92
10.64%
1.06K
12.85%
1.15K
8.86%
1.40K
22.11%
capex per share
-62.50
-
-89.99
44.00%
-87.22
3.08%
-245.93
181.97%
-66.59
72.92%
-45.15
32.19%
-36.89
18.30%
-75.74
105.33%
-114.83
51.62%
-113.62
1.06%
capex to depreciation
-1.50
-
-1.89
26.53%
-1.45
23.31%
-3.63
150.43%
-0.94
74.05%
-0.61
34.84%
-0.49
20.21%
-0.98
100.21%
-1.61
64.12%
-1.51
6.34%
capex to operating cash flow
-0.55
-
-0.61
12.14%
-0.36
41.10%
-1.91
428.26%
-0.61
67.85%
-0.26
57.39%
-0.20
21.48%
-0.35
71.69%
-0.68
92.63%
-0.32
52.72%
capex to revenue
-0.08
-
-0.10
28.64%
-0.10
7.04%
-0.29
202.72%
-0.08
73.29%
-0.05
37.38%
-0.04
28.07%
-0.07
89.04%
-0.09
34.20%
-0.08
13.65%
cash per share
344.72
-
433.98
25.89%
439.70
1.32%
194.46
55.77%
126.43
34.98%
149.21
18.02%
155.27
4.06%
208.47
34.26%
267.45
28.29%
402.02
50.32%
days of inventory on hand
155.35
-
148.41
4.47%
149.55
0.77%
166.73
11.49%
161.55
3.11%
174.04
7.74%
158.82
8.75%
191.30
20.46%
184.71
3.45%
414.02
124.15%
days payables outstanding
68.01
-
61.97
8.88%
71.92
16.05%
78.41
9.04%
89.15
13.68%
75.43
15.39%
48.66
35.48%
92.32
89.71%
92.83
0.55%
192.97
107.88%
days sales outstanding
116.87
-
124.17
6.25%
118.60
4.49%
127.40
7.43%
116.12
8.86%
102.65
11.60%
129.10
25.76%
100.78
21.93%
119.26
18.33%
107.60
9.77%
debt to assets
0.26
-
0.22
15.76%
0.16
27.11%
0.22
38.64%
0.22
0.47%
0.17
24.26%
0.10
44.10%
0.11
19.95%
0.11
0.06%
0.04
63.42%
debt to equity
0.49
-
0.39
21.37%
0.26
32.60%
0.40
51.84%
0.40
1.14%
0.27
31.73%
0.14
47.91%
0.17
21.46%
0.18
2.56%
0.06
67.43%
dividend yield
0.01
-
0.01
11.83%
0.01
31.39%
0.01
2.58%
0.01
46.09%
0.01
23.55%
0.01
12.29%
0.01
26.85%
0.01
5.08%
0.01
11.49%
earnings yield
0.05
-
0.04
24.35%
0.04
3.58%
0.03
29.02%
0.03
1.05%
0.04
46.16%
0.04
7.02%
0.03
32.16%
0.03
29.37%
0.06
77.55%
enterprise value
447.19B
-
597.66B
33.65%
511.20B
14.47%
469.73B
8.11%
401.67B
14.49%
499.86B
24.44%
537.39B
7.51%
764.43B
42.25%
731.53B
4.30%
775.22B
5.97%
enterprise value over ebitda
17.18
-
22.74
32.36%
17.26
24.09%
34.80
101.63%
33.71
3.14%
21.17
37.18%
10.85
48.76%
15.65
44.20%
13.90
11.18%
7.13
48.72%
ev to operating cash flow
22.98
-
23.87
3.91%
12.39
48.09%
21.83
76.17%
22.28
2.04%
17.41
21.84%
18.01
3.41%
21.41
18.89%
26.03
21.55%
13.17
49.41%
ev to sales
3.38
-
4.03
19.20%
3.30
18.07%
3.34
0.96%
2.83
15.22%
3.25
14.88%
3.08
5.27%
4.03
30.91%
3.41
15.31%
3.15
7.60%
free cash flow per share
51.96
-
56.99
9.67%
154.63
171.34%
-116.84
175.56%
42.12
136.05%
127.85
203.52%
143.12
11.94%
139.54
2.50%
54.61
60.86%
240.97
341.25%
free cash flow yield
0.02
-
0.02
19.40%
0.05
211.88%
-0.04
187.12%
0.02
144.51%
0.05
131.55%
0.05
0.25%
0.03
32.62%
0.01
58.85%
0.05
310.01%
graham net net
134.85
-
240.90
78.64%
270.69
12.37%
-73.47
127.14%
-179.34
144.10%
-67.70
62.25%
74.41
209.92%
36.53
50.91%
97.76
167.61%
334.01
241.66%
graham number
1.23K
-
1.38K
12.24%
1.41K
1.86%
1.10K
21.96%
1.01K
8.43%
1.47K
45.71%
1.57K
7.18%
1.66K
5.26%
1.92K
15.74%
2.93K
52.75%
income quality
0.90
-
1.13
24.75%
2.06
82.60%
1.79
13.30%
1.84
2.89%
1.53
16.93%
1.53
0.21%
1.86
21.82%
1.19
36.03%
0.97
18.39%
intangibles to total assets
0.09
-
0.08
2.29%
0.12
40.68%
0.22
86.58%
0.22
2.70%
0.21
0.62%
0.14
36.35%
0.15
11.14%
0.11
29.54%
0.11
5.04%
interest coverage
20.43
-
24.07
17.81%
35.86
48.97%
21.29
40.63%
15.12
28.97%
17.96
18.76%
37.70
109.88%
37.18
1.38%
42.61
14.61%
67.42
58.25%
interest debt per share
270.61
-
259.63
4.06%
201.35
22.45%
298.95
48.47%
310.54
3.88%
238.34
23.25%
139.25
41.57%
188.60
35.43%
209.80
11.24%
89.74
57.23%
inventory turnover
2.35
-
2.46
4.68%
2.44
0.76%
2.19
10.31%
2.26
3.21%
2.10
7.18%
2.30
9.59%
1.91
16.98%
1.98
3.57%
0.88
55.39%
invested capital
0.49
-
0.39
21.37%
0.26
32.60%
0.40
51.84%
0.40
1.14%
0.27
31.73%
0.14
47.91%
0.17
21.46%
0.18
2.56%
0.06
67.43%
market cap
435.98B
-
594.18B
36.29%
517.65B
12.88%
438.68B
15.26%
353.60B
19.39%
463.70B
31.14%
517.35B
11.57%
748.95B
44.77%
712.54B
4.86%
767.53B
7.72%
net current asset value
24.32B
-
36.38B
49.55%
40.37B
10.98%
4.60B
88.61%
10.50B
128.38%
29.27B
178.74%
53.12B
81.47%
57.74B
8.70%
74.98B
29.86%
114.27B
52.40%
net debt to ebitda
0.43
-
0.13
69.32%
-0.22
264.66%
2.30
1,157.62%
4.03
75.38%
1.53
62.04%
0.40
73.57%
0.32
21.74%
0.36
13.88%
0.07
80.40%
net income per share
126.51
-
130.22
2.94%
117.35
9.89%
72.24
38.44%
59.13
18.15%
113.28
91.59%
117.62
3.83%
115.46
1.83%
142.08
23.05%
271.47
91.07%
operating cash flow per share
114.46
-
146.98
28.41%
241.85
64.55%
129.09
46.62%
108.71
15.79%
173.00
59.14%
180.01
4.05%
215.28
19.59%
169.45
21.29%
354.59
109.26%
payables turnover
5.37
-
5.89
9.74%
5.08
13.83%
4.65
8.29%
4.09
12.04%
4.84
18.18%
7.50
55.00%
3.95
47.29%
3.93
0.54%
1.89
51.90%
receivables turnover
3.12
-
2.94
5.88%
3.08
4.70%
2.86
6.91%
3.14
9.72%
3.56
13.12%
2.83
20.48%
3.62
28.09%
3.06
15.49%
3.39
10.83%
research and ddevelopement to revenue
0.09
-
0.12
25.49%
0.12
2.10%
0.14
20.45%
0.13
7.38%
0.10
21.12%
0.09
13.00%
0.09
1.22%
0.08
6.47%
0.08
3.33%
return on tangible assets
0.14
-
0.12
10.08%
0.11
12.07%
0.07
35.67%
0.06
21.24%
0.11
91.49%
0.10
8.38%
0.09
12.55%
0.09
4.63%
0.16
76.79%
revenue per share
777.27
-
870.09
11.94%
907.12
4.26%
844.94
6.85%
856.39
1.35%
927.28
8.28%
1.05K
13.58%
1.14K
8.62%
1.29K
12.98%
1.48K
14.58%
roe
0.24
-
0.20
15.89%
0.16
21.74%
0.10
37.76%
0.08
20.10%
0.13
72.89%
0.13
6.16%
0.11
13.01%
0.12
13.03%
0.19
56.48%
roic
0.15
-
0.13
13.49%
0.13
0.70%
0.06
52.47%
0.05
28.17%
0.10
113.02%
0.22
129.45%
0.12
47.83%
0.13
12.13%
0.29
121.16%
sales general and administrative to revenue
0.19
-
shareholders equity per share
533.98
-
653.51
22.38%
752.49
15.15%
744.34
1.08%
762.52
2.44%
844.99
10.82%
934.92
10.64%
1.06K
12.85%
1.15K
8.86%
1.40K
22.11%
stock based compensation to revenue
0.00
-
0.00
1.87%
0.00
9.41%
0.00
7.16%
0.00
13.09%
0.00
20.90%
0.00
18.02%
0.00
3.16%
0.00
10.29%
0.00
41.53%
tangible asset value
76.10B
-
94.87B
24.66%
103.69B
9.30%
75.37B
27.32%
77.85B
3.29%
91.93B
18.08%
123.33B
34.16%
134.76B
9.27%
158.86B
17.88%
196.66B
23.79%
tangible book value per share
447.55
-
557.04
24.46%
607.99
9.15%
452.25
25.62%
469.41
3.80%
554.06
18.03%
743.99
34.28%
812.60
9.22%
957.68
17.85%
1.18K
23.68%
working capital
49.68B
-
55.84B
12.40%
55.04B
1.43%
15.38B
72.07%
39.95B
159.86%
54.80B
37.16%
57.56B
5.03%
66.78B
16.02%
83.26B
24.69%
118.53B
42.36%

All numbers in USD (except ratios and percentages)